Search results for "Coronavirus"
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
ACP issues guidance on easing social distancing, recognizes role of internists during the pandemic
The College addressed what communities need to safely resume economic activities and in-person medical visits, and released a new video emphasizing the essential role of the internal medicine community.
https://immattersacp.org/weekly/archives/2020/05/12/2.htm
12 May 2020
CDC recommendations on COVID-19 vaccine boosters, new data on vaccine effectiveness
Several groups in the U.S. are now eligible to receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine at least six months after completing the initial two-dose series.
https://immattersacp.org/weekly/archives/2021/09/28/1.htm
28 Sep 2021
Antibody therapy gets EUA, studies show pandemic's effects on emergency care
Sotrovimab received an emergency use authorization (EUA) for some high-risk outpatients with COVID-19, and multiple studies found changed patterns in cardiac emergencies and care associated with the pandemic.
https://immattersacp.org/weekly/archives/2021/06/08/1.htm
8 Jun 2021
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021
Psychological, disparate effects of the pandemic detailed by recent research
Mental health problems were prevalent among U.S. adults in June, obesity is strongly associated with mortality from COVID-19, and an inactivated vaccine has shown promise in a phase 1/2 Chinese trial.
https://immattersacp.org/weekly/archives/2020/08/18/1.htm
18 Aug 2020
Q&A: Dealing with COVID-19 vaccine allocation, distribution
The new availability of vaccines has highlighted the challenges of allocation and distribution, which were the focus of a recent forum hosted by ACP and Annals of Internal Medicine.
https://immattersacp.org/weekly/archives/2021/02/02/2.htm
2 Feb 2021
Latest research on COVID-19 antibodies, cardiac and stroke risks, mortality rates
A monoclonal antibody treatment showed benefit in outpatients, data varied on duration of antibody response, cardiac effects appeared common while strokes were not, and mortality improved, among other recent findings on COVID-19.
https://immattersacp.org/weekly/archives/2020/11/03/1.htm
3 Nov 2020
New data on delta variant of COVID-19 and vaccines
Recent research found that the risk of myocarditis and both arterial and venous clots is higher with COVID-19 infection than with vaccine administration. Other studies show that the COVID-19 delta variant has been associated with reduced mRNA vaccine effectiveness (from 91% to 66%) and an overall increased severity of illness.
https://immattersacp.org/weekly/archives/2021/08/31/1.htm
31 Aug 2021